NogueronEBerrocalAAlbertACampsCVincentJM. Acute cerebellar syndrome due to 5-fluorouracil. Rev Neurol1997;25:2053–4.
2.
KoenigHPatelA. The role of Kreb's cycle inhibition by fluoroacetate. Arch Neurol1970;23:155–60.
3.
DavisSTJoynerSSBacanariDPSpectorT. 5-Ethynyluracil (776C85): Protection from 5-fluorouracil-induced neurotoxicity in dogs. Biochem Pharmacol1994;48:233–6.
4.
KimmelDSchuttA. Multifocal leukoencephalopathy: Occurrence during 5-fluorouracil and levamisole therapy and resolution after discontinuation of chemotherapy. Mayo Clin Proc1993;68:363–5.
5.
NaranjoCABustoUSellersEMSandorPRuizIRobertsEAA method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981;30:239–45.